Indies Pharma Jamaica Limited (JMSE:INDIES)

Market Cap	5.02B
Revenue (ttm)	1.16B
Net Income (ttm)	251.77M
Shares Out	1.33B
EPS (ttm)	0.19
PE Ratio	19.95
Forward PE	n/a
Dividend	0.11 (2.92%)
Ex-Dividend Date	n/a

Volume	47,954
Average Volume	92,392
Open	n/a
Previous Close	3.300
Day's Range	3.250 - 3.360
52-Week Range	2.250 - 4.180
Beta	0.36
RSI	60.09
Earnings Date	Mar 14, 2025

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 65
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: INDIES

Financial Performance

In 2024, Indies Pharma Jamaica's revenue was 1.16 billion, an increase of 9.81% compared to the previous year's 1.06 billion. Earnings were 251.77 million, an increase of 15.69%.